ArticleRedox biology2017
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.
Sebastian Steven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
161 papers cite itlatest 60 shown
this paperpooled ittrialcites it